Cargando…

Drug–Drug–Gene Interactions in Cardiovascular Medicine

Cardiovascular disease remains a leading cause of both morbidity and mortality worldwide. It is widely accepted that both concomitant medications (drug–drug interactions, DDIs) and genomic factors (drug–gene interactions, DGIs) can influence cardiovascular drug-related efficacy and safety outcomes....

Descripción completa

Detalles Bibliográficos
Autores principales:	Asiimwe, Innocent G, Pirmohamed, Munir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639705/ https://www.ncbi.nlm.nih.gov/pubmed/36353710 http://dx.doi.org/10.2147/PGPM.S338601

Ejemplares similares

Cardiovascular drugs and COVID‐19 clinical outcomes: A living systematic review and meta‐analysis
por: Asiimwe, Innocent G., et al.
Publicado: (2021)

Cardiovascular drugs and COVID‐19 clinical outcomes: a systematic review and meta‐analysis of randomized controlled trials
por: Asiimwe, Innocent G., et al.
Publicado: (2022)

Ethnic Diversity and Warfarin Pharmacogenomics
por: Asiimwe, Innocent G., et al.
Publicado: (2022)

Drug Induced Hypersensitivity and the HLA Complex
por: Alfirevic, Ana, et al.
Publicado: (2010)

A reference set of clinically relevant adverse drug-drug interactions
por: Kontsioti, Elpida, et al.
Publicado: (2022)

Warfarin dosing algorithms: A systematic review
por: Asiimwe, Innocent G., et al.
Publicado: (2020)

Similarity and consistency assessment of three major online drug–drug interaction resources
por: Kontsioti, Elpida, et al.
Publicado: (2022)

Parsing interindividual drug variability: an emerging role for systems pharmacology
por: Turner, Richard M, et al.
Publicado: (2015)

Cardiac Drugs in ACHD Cardiovascular Medicine
por: Ladouceur, Magalie, et al.
Publicado: (2023)

Precision Medicine and Adverse Drug Reactions Related to Cardiovascular Drugs †
por: Noyes, James D., et al.
Publicado: (2021)

New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity
por: Pirmohamed, Munir, et al.
Publicado: (2015)

Metabolism-involved drug interactions with traditional Chinese medicines in cardiovascular diseases
por: Liang, Ren-Jong, et al.
Publicado: (2022)

The Influence of Pharmacogenetics on the Clinical Relevance of Pharmacokinetic Drug–Drug Interactions: Drug–Gene, Drug–Gene–Gene and Drug–Drug–Gene Interactions
por: Hahn, Martina, et al.
Publicado: (2021)

Understanding and preventing drug–drug and drug–gene interactions
por: Tannenbaum, Cara, et al.
Publicado: (2014)

Medicinal Cannabis—Potential Drug Interactions
por: Alsherbiny, Muhammad A., et al.
Publicado: (2018)

Drug–drug–gene interactions and adverse drug reactions
por: Malki, Mustafa Adnan, et al.
Publicado: (2019)

Clinical Relevance of Drug–Drug Interactions With Antibiotics as Listed in a National Medication Formulary: Results From Two Large Population‐Based Case‐Control Studies in Patients Aged 65–100 Years Using Linked English Primary Care and Hospital Data
por: van Staa, Tjeerd Pieter, et al.
Publicado: (2022)

Warfarin: The End or the End of One Size Fits All Therapy?
por: Pirmohamed, Munir
Publicado: (2018)

The Interface of Therapeutics and Genomics in Cardiovascular Medicine
por: Magavern, E. F., et al.
Publicado: (2021)

Focus on the Lymphatic Route to Optimize Drug Delivery in Cardiovascular Medicine
por: Tessier, Nolwenn, et al.
Publicado: (2021)

Optimising migraine treatment: from drug-drug interactions to personalized medicine
por: Pomes, Leda Marina, et al.
Publicado: (2019)

Multimorbidity, polypharmacy, and drug-drug-gene interactions following a non-ST elevation acute coronary syndrome: analysis of a multicentre observational study
por: Turner, R. M., et al.
Publicado: (2020)

Causality Patterns for Detecting Adverse Drug Reactions From Social Media: Text Mining Approach
por: Bollegala, Danushka, et al.
Publicado: (2018)

Herbal Medicine for Pain Management: Efficacy and Drug Interactions
por: Jahromi, Behdad, et al.
Publicado: (2021)

Repurposing drugs to treat cardiovascular disease in the era of precision medicine
por: Abdelsayed, Mena, et al.
Publicado: (2022)

Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions
por: Osanlou, Rostam, et al.
Publicado: (2022)

Enhancing Communication about Paediatric Medicines: Lessons from a Qualitative Study of Parents' Experiences of Their Child's Suspected Adverse Drug Reaction
por: Arnott, Janine, et al.
Publicado: (2012)

Polygenic risk scores: An overview from bench to bedside for personalised medicine
por: Cross, Benjamin, et al.
Publicado: (2022)

Unravelling the complex drug–drug interactions of the cardiovascular drugs, verapamil and digoxin, with P-glycoprotein
por: Ledwitch, Kaitlyn V., et al.
Publicado: (2016)

Potential Pharmacokinetic Interactions of Common Cardiovascular Drugs and Selected European and Latin American Herbal Medicines: A Scoping Review
por: Prieto-Garcia, Jose M., et al.
Publicado: (2023)

Clinical coding of prospectively identified paediatric adverse drug reactions – a retrospective review of patient records
por: Bellis, Jennifer R, et al.
Publicado: (2014)

The Challenge and Importance of Integrating Drug–Nutrient–Genome Interactions in Personalized Cardiovascular Healthcare
por: Stouras, Ioannis, et al.
Publicado: (2022)

Potential herb–drug interactions between anti-COVID-19 drugs and traditional Chinese medicine
por: Ye, Ling, et al.
Publicado: (2023)

Drug-microbiota interactions: an emerging priority for precision medicine
por: Zhao, Qing, et al.
Publicado: (2023)

Medicinal importance of grapefruit juice and its interaction with various drugs
por: Kiani, Jawad, et al.
Publicado: (2007)

Pharmacogenomics and circadian rhythms as mediators of cardiovascular drug-drug interactions
por: Geng, Yong-Jian, et al.
Publicado: (2021)

Characterization of Teicoplanin-Specific T-Cells from Drug Naïve Donors Expressing HLA-A*32:01
por: Gardner, Joshua, et al.
Publicado: (2022)

Reporting of drug induced depression and fatal and non-fatal suicidal behaviour in the UK from 1998 to 2011
por: Thomas, Kyla H, et al.
Publicado: (2014)

Update of green tea interactions with cardiovascular drugs and putative mechanisms
por: Werba, José Pablo, et al.
Publicado: (2018)

Drug-drug interactions with raltegravir
por: Burger, David M
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_h23u4dl4833a9lo0gv92ba5ofc